TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -4 | 3 | -2 | -22 | -7 | -6 |
| S | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/15 21:56 | 9/22/15 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Goldberg Y. Paul | A1 | O | VP of Cl | M.d | 99 | 3.24 | 0 | 30 | 6 | D | -48 | -33 | -9 | -12 | -3 | -6 | -2 | -4 | 3 | -2 | -22 | -7 | |||
9/24/15 21:56 | 9/22/15 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Goldberg Y. Paul | A1 | O | VP of Cl | S.dm | -197 | 8.88 | 0 | -22 | -79 | 6 | D | -48 | -33 | -9 | -12 | -3 | -6 | -2 | -4 | 3 | -2 | -22 | -7 | ||
8/20/15 13:04 | 8/18/15 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Goldberg Y. Paul | A1 | O | VP of Cl | M.d | 15 | 4.92 | 0 | 3 | 102 | 6 | D | -48 | -17 | 3 | -8 | 6 | 3 | 1 | 1 | -10 | -21 | -29 | -25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |